18 January 2022 - Canada’s health regulator has approved a pill by Pfizer that treats the effects of COVID-19.
Health Canada authorised Paxlovid for adult patients with mild or moderate COVID-19 who are also at high risk of becoming more seriously ill.
Health Canada did not authorise it for use on teenagers or on patients who are already hospitalised because of COVID-19.